Search Results

You searched for : Takeda  

Biofourmis enters the Unicorn Club

Boston-based healthtech startup Biofourmis enters the Unicorn Club ($1 billion in valuation). The startup raised $300 million in its Series D funding round led ...
Apr 27

Chronic Disease Management with USA’s Biofourmis

CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. Learn how ...
Feb 26

Biomarker startup Koneksa gains $45 million

Digital biomarker startup Koneksa has raised $45 million in their Series C funding round....
Feb 08

Wave Life Sciences and Takeda Amend CNS Collaboration

...
Oct 20

Takeda to commercialize Hunter Syndrome Therapy through collaboration with JCR Pharmaceuticals

Latest pharma news update...
Oct 04

Japan suspends use of about 1.63 million doses of Moderna vaccine due to contamination

Japan covid news update...
Aug 28

The liver performs 500 functions at the same time and is like the supercomputer of the body, says Dr. Vikram Raut

Dr. Vikram Raut Senior Consultant and Lead Liver Transplant Surgeon explains the signs and symptoms of liver disease and guides how to take care of ...
May 01

Takeda acquires Maverick Therapeutics for around $ 525 million benefit

Takeover to advance T-Cell Activator Solid Tumor Treatments and expand new Cancer Immunotherapy Portfolio...
Mar 13

Crescendo Biologics expands its ongoing collaboration with Takeda

This collaboration will help Crescendo’s proprietary transgenic platform and engineering expertise are being used to build Humabody-based therapeutics against certain targets selected by ...
Dec 11

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-...
Dec 04

Takeda completes sale of select OTC and non-core assets to Celltrion in Asia Pacific

Takeda Pharmaceutical Company Limited completes its previously-announced sale of a portfolio of select products to Celltrion Inc...
Dec 01

Bio and Pharma Integrates 2020: Live Online 16 & 17 November 2020

The digital networking space offers real-time, face-to-face engagement, which maximises chance encounters with other attendees...
Nov 12

Fast Track designation facilitates development of new therapies that treat serious conditions and fulfill unmet needs for patients

LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA) ...
Nov 04

Takeda collaborates with Moderna to supply COVID-19 vaccine in Japan

Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan ...
Oct 29

Takeda accelerates digital transformation with Accenture and AWS

Collaboration will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs and develop the workforce of the future ...
Oct 13

Takeda Pharmaceutical has built new cell drug manufacturing facility for R & D

Takeda establishes new cell drug manufacturing facility for research and development to support expansion of next-generation clinical programs ...
Sep 19

Europe’s largest initiative launches to accelerate therapy development for COVID-19 and future Coronavirus threats

CARE aims to create effective therapies with a positive safety profile for the COVID-19 pandemic and develop new drugs and antibodies specially designed to ...
Aug 19

Glenmark appoints Dipankar Bhattacharjee to its Board of Directors

Glenmark Pharmaceuticals announced the appointment of Mr Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization...
Aug 18

Novavax and Takeda Announce collaboration for Novavax’ COVID-19 vaccine candidate in Japan

Novavax partners with Takeda for manufacturing and marketing covid vaccine in Japan...
Aug 08

U.S. FDA approves Takeda’s ALUNBRIG for lung cancer patients

U.S. FDA Approves Takeda’s ALUNBRIG (brigatinib) as a first-line treatment option for patients diagnosed with rare and serious form of lung cancer ...
May 23

Takeda Announces Financial Results for Past Year

Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum ...
May 14

EC approves subcutaneous formulation of Entyvio for maintenance therapy in adults with Crohn's disease or Ulcerative Colitis

...
May 08

Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Orifarm for Up to Approximately $670M USD

Portfolio includes select OTC and prescription products and two manufacturing facilities ...
Apr 27

Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial

Multiple myeloma is a life-threatening rare blood cancer that arises from the plasma cells, a type of white blood cell that is made in ...
Mar 12

Roche Arthritis drug Actemra is being used to Combat COVID-19 in China.

Roche has donated $2 million worth of Actemra to China before the anti-inflammatory med was officially added to Chinese authorities COVID-19 treatment guidelines. ...
Mar 06

25 Matching result(s) found!

-Advertisements-




Trending Now

Moving Towards Better Mental Health: Know The Impact of Low-intensity Workout For Your Mental Well-being April 29, 2024
Exploring Mortality Risks for Lesbian and Bisexual Women: Key Findings from a Comprehensive Research EffortApril 29, 2024
Implications of Alcohol Intake During Pregnancy on Fetal Development: New Study Reveals Subtle ChangesApril 29, 2024
Indian Air Force's Night Vision Rescue: Soldier’s Life Saved in High-Stakes AirliftApril 29, 2024
Now You Can Also Buy Insurance For Your Parents Aged Above 65 years: IRDAI Lifts Age Cap for Health Insurance Expanding Healthcare AccessApril 29, 2024
Ensuring Infection Control: Central Government Hospitals Implement New Safety MeasuresApril 29, 2024
Dish TV Revolutionizes Entertainment with ‘Dish TV Smart+’ Services, Offering TV and OTT on Any Screen, AnywhereApril 26, 2024
Arohan Financial Services Recognized Among India's Best Workplaces in BFSI 2024April 26, 2024
Why Podcasts Are the Next Big Thing in Healthcare Advertising in IndiaApril 26, 2024
Challenges of Child Growth at High Altitudes: New Study Reveals ImpactApril 26, 2024
Staying Cool in India's Scorching Heat: Heatwave Safety TipsApril 26, 2024
The Dark Side of Neotame (Artificial Sweetener): New Research Raises Concerns about Gut HealthApril 26, 2024
Sightsavers India Fellowship Program Invites Applications for Promising OphthalmologistsApril 25, 2024
Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024